Which Patients with Estrogen Receptor-Positive Early Breast Cancer Should Be Treated with Adjuvant Chemotherapy?

Publisher： Karger

E-ISSN： 1423-0232|77|1|18-22

ISSN： 0030-2414

Source： Oncology, Vol.77, Iss.1, 2010-02, pp. : 18-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Preoperative Neutrophil/Lymphocyte Ratio Does not Correlate with the 21-Gene Recurrence Score in Estrogen Receptor-Positive Breast Cancer Patients

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 24-27

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy for the Treatment of HER2-Positive Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 14-17

Karger

Access to resources Recommend Favorite

Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 554-558

Karger

Access to resources Recommend Favorite

Herpes Infections in Breast Cancer Patients Treated with Adjuvant Chemotherapy

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 164-167

Karger

Access to resources Recommend Favorite

Physical activity and survival of postmenopausal, hormone receptor–positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2847-2854

John Wiley & Sons Inc

Access to resources Recommend Favorite